Diversity of breast carcinoma: Histological subtypes and clinical relevance

Clinical Medicine Insights: Pathology

Volumn 8, Issue 1, 2015, Pages 23-31

  Makki, Jaafar ^a  

^a Queen Elizabeth Hospital   (Malaysia)

Author keywords

Breast cancer; Histological variant of breast carcinoma; Invasive ductal carcinoma; Lobular carcinoma; Molecular classification

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; TAMOXIFEN; TRASTUZUMAB;

ACINAR CELL CARCINOMA; ADENOID CYSTIC CARCINOMA; ARTICLE; BREAST CARCINOMA; BREAST HISTIOCYTOID CARCINOMA; BREAST INVASIVE MICROPAPILLARY CARCINOMA; BREAST INVASIVE PAPILLARY CARCINOMA; BREAST LIPID RICH CARCINOMA; BREAST LUMINAL A CARCINOMA; BREAST LUMINAL B CARCINOMA; BREAST MEDULLARY CARCINOMA; BREAST METAPLASTIC CARCINOMA; BREAST MUCINOUS CARCINOMA; BREAST PLEOMORPHIC LOBULAR CARCINOMA; BREAST SECRETORY CARCINOMA; BREAST SIGNET RING CARCINOMA; BREAST TUBULAR CARCINOMA; BREAST TUBULOLOBULAR CARCINOMA; CANCER CLASSIFICATION; CANCER GRADING; CANCER INCIDENCE; CANCER MORTALITY; CANCER PROGNOSIS; DEVELOPED COUNTRY; DISEASE ACTIVITY; DISEASE COURSE; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; LIFESTYLE; MOLECULAR DIAGNOSIS; NEU GENE; NEUROENDOCRINE TUMOR; PREDICTION; TISSUE STRUCTURE; TUMOR INVASION;

EID: 84982055971     PISSN: 11795557     EISSN: None     Source Type: Journal    
DOI: 10.4137/CPath.s31563     Document Type: Article

References (28)

1. Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, Van de Vijver MJ, eds. WHO Classification of Tumours of the Breast. Fourth ed. IARC, Lyon; 2012. ISBN.13.
2. Peter B, Bernard L. World Cancer Report. International Agency for Research on Cancer; WHO Press, Lyon, France; 2008.
3. Fattaneh AT, Peter D. WHO Classification Pathology and Genetics of Tumours of the Breast and Female Genital Organs. IARC Press, Lyon, France; 2003.
4. Vinay K, Abul KA, Jon CA, Nelson F. Robbins and Cotran Pathologic Basis of Disease. Eight ed. Elsevier, Lyon, France; 2010.
5. Eheman CR, Shaw KM, Ryerson AB, Miller JW, Ajani UA, White MC. The changing incidence of in situ and invasive ductal and lobular breast carcinomas. Cancer Epidemiol Biomarkers Prev. 2009;18(6):1763-9.
6. Rosai J. Rosai and Ackerman's Surgical Pathology. Tenth ed. Elsevier, Lyon, France; 2011.
7. Coyne JD. DCIS and LCIS with multinucleated giant cells - a report of 4 cases. Histopathology. 2007;50:669-71.
8. Leal C, Rui H, Paula M, et al. Apocrine ductal carcinoma in situ of the breast: histologic classification and expression of biologic markers. Hum Pathol. 2001;32:487-93.
9. Hayes MM, Peterse JL, Yavuz E, Vischer GH, Eusebi V. Squamous cell carcinoma in situ of the breast: a light microscopic and immunohistochemical study of a previously undescribed lesion. Am J Surg Pathol. 2007;31:1414-9.
10. Farabegoli F, Champeme MH, Bieche I, Santini D, Ceccarelli C, Derenzini M. Genetic pathways in the evolution of breast ductal carcinoma in situ. J Pathol. 2002;196:280-6.
11. Hanby AM, Hughes TA. In situ and invasive lobular neoplasia of the breast. Histopathology. 2008;52:58-66.
12. Schnitt SJ, Morrow M. Lobular carcinoma in situ. current concepts and controversies. Semin Diagn Pathol. 1999;16:209-3.
13. Mastracci TL, Tjan S, Bane AL, O'Malley FP, Andrulis IL. E-cadherin alterations in atypical lobular hyperplasia and lobular carcinoma in situ of the breast. Mod Pathol. 2005;18:741-51.
14. Tien Y, Carolyn M. Application of immunohistochemistry to breast lesions. Arch Pathol Lab Med. 2008;132:349-58.
15. Farid M. Essentials of Diagnostic Breast Pathology, Practical Approach. 1st ed. Berlin: Springer; 2007. ISBN 978-3-540-45117-4.
16. Rosen PP. Rosen's Breast Pathology. 3rd ed. Lippincott Williams & Wilkins, Lyon, France; 2009.
17. Armes JE, Venter DJ. The pathology of inherited breast cancer. Pathology. 2002;34:309-14.
18. Hind N, Tracy W, Aleodor A, Jyotirmoy D, Volkan A, Daniel V. Clinicopathologic analysis of invasive micropapillary. Mod Pathol. 2001;14:836-41.
19. Yerushalmi R, Hayes MM, Gelmon KA. Breast carcinoma - rare types: review of the literature. Ann Oncol. 2009;20:1763-70.
20. Colome MI, Ro JY, Ayala AG. Adenoid cystic carcinoma of the breast metastatic to the kidney. J Pathol Bacteriol. 1996;4:69-78.
21. Cristofanilli M, Gonzalez-Angulo A, Sneige N, et al. Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes. J Clin Oncol. 2005;23:41-8.
22. Chen YY, Hwang ES, Roy R, et al. Genetic and phenotypic characteristics of pleomorphic lobular carcinoma in situ of the breast. Am J Surg Pathol. 2009;33:1683-94.
23. Perou CM, Sørlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature. 2000;406:747-52.
24. Peter S, Lakhani SR. Recent developments in the molecular pathology of breast cancer. Breast Cancer. 2009;98:23-7.
25. Shawarby MA, Al-Tamimi DM, Ahmed A. Molecular classification of breast cancer: an overview with emphasis on ethnic variations and future perspectives. Saudi J Med Med Sci. 2013;1:14-9.
26. Schnitt SJ. Will molecular classification replace traditional breast pathology? Int J Surg Pathol. 2010;18:162S-6.
27. Correa Geyer F, Reis-Filho JS. Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet? Int J Surg Pathol. 2009;17:285-302.
28. Makki J, Myint O, Wynn AA, Samsudin AT, John DV. Expression distribution of cancer stem cells, epithelial to mesenchymal transition, and telomerase activity in breast cancer and their association with clinicopathologic characteristics. Clin Med Insights Pathol. 2015;8:1-16.